Toho Holdings Co (FRA:TON) Sloan Ratio %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TON Toho Holdings Co Ltd FRA:TON
86 GF Score
Price €21.40
GF Value €25.57
! 3 Warning Signs
View Full Analysis

What is Toho Holdings Co Sloan Ratio %?

Toho Holdings Co FRA:TON -2.73% 86 Sloan Ratio % is 0.00% as of Mar. 2026. GuruFocus rates FRA:TON with a GF Score™ of 86/100 and a GF Value™ of €25.57. The stock has 3 warning signs investors should review.

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Toho Holdings Co's Sloan Ratio for the quarter that ended in Mar. 2026 was 0.00%.

As of Mar. 2026, Toho Holdings Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Toho Holdings Co  (FRA:TON) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2026, Toho Holdings Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Toho Holdings Co Sloan Ratio % Related Terms


Toho Holdings Co Sloan Ratio % Historical Data

* Premium members only.

The historical data trend for Toho Holdings Co's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Toho Holdings Co Sloan Ratio % Chart

Toho Holdings Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.15 1.30 -6.25 7.01 -0.37

Toho Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:TON vs MCK, COR, CAH: Sloan Ratio % Comparison

For the Medical Distribution subindustry, Toho Holdings Co's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Toho Holdings Co Sloan Ratio % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Toho Holdings Co's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Toho Holdings Co's Sloan Ratio % falls into.


FRA:TON
86GF Score
Toho Holdings Co Ltd FRA:TON
Sloan Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Toho Holdings Co Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Toho Holdings Co's Sloan Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Sloan Ratio=(Net Income (A: Mar. 2026 )-Cash Flow from Operations (A: Mar. 2026 )
-Cash Flow from Investing (A: Mar. 2026 ))/Total Assets (A: Mar. 2026 )
=(94.452-104.896
-4.481)/4038.093
=-0.37%

Toho Holdings Co's Sloan Ratio for the quarter that ended in Mar. 2026 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2026 )
=(97.408-0
-0)/4038.093
=2.41%

Toho Holdings Co's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was 20.12 (Jun. 2025 ) + 16.658 (Sep. 2025 ) + 44.936 (Dec. 2025 ) + 15.694 (Mar. 2026 ) = €97 Mil.
Toho Holdings Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 0 (Jun. 2025 ) + 0 (Sep. 2025 ) + 0 (Dec. 2025 ) + 0 (Mar. 2026 ) = €0 Mil.
Toho Holdings Co's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 was 0 (Jun. 2025 ) + 0 (Sep. 2025 ) + 0 (Dec. 2025 ) + 0 (Mar. 2026 ) = €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Sloan Ratio % →
What does a Sloan Ratio % of 0.00% mean?
Toho Holdings Co (FRA:TON) has a Sloan Ratio % of 0.00% as of Mar. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Toho Holdings Co and its competitors.
Is Toho Holdings Co's Sloan Ratio % too high?
Toho Holdings Co's current Sloan Ratio % is 0.00%. Overall, Toho Holdings Co has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Toho Holdings Co's Sloan Ratio % compare to MCK and COR?
Toho Holdings Co's Sloan Ratio % of 0.00% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Medical Distribution company?
A good Sloan Ratio % depends on the Medical Distribution industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Toho Holdings Co and its competitors. Toho Holdings Co's current Sloan Ratio % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Toho Holdings Co stock overvalued right now?
Toho Holdings Co (FRA:TON) has a current Sloan Ratio % of 0.00%. The stock's GF Value™ is €25.57, compared to a current price of €21.40 — trading 16.3% below its estimated fair value. The current Sloan Ratio % is 0.00%. Toho Holdings Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Toho Holdings Co (FRA:TON), the current Sloan Ratio % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Toho Holdings Co (FRA:TON) Overvalued in 2026?

Based on GuruFocus' analysis, Toho Holdings Co stock appears to be undervalued. The current stock price of €21.40 is trading 16.3% below its estimated GF Value™ of €25.57.

Key valuation signals for FRA:TON:

  • Sloan Ratio %: 0.00%
  • GF Value™: €25.57 vs. price of €21.40 (16.3% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the FRA:TON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Toho Holdings Co Business Description

Other Exchanges 8129:Japan
Address 4-43-11 Daizawa, Setagaya-ku, Tokyo, JPN, 155-8655
Toho Holdings Co Ltd is a specialty and generic drug manufacturing company. The company's business includes pharmaceutical wholesaling and pharmacy dispensing. It also maintains a site-management organization business that assists a variety of medical establishments, ranging from large medical institutions to private clinics, with a wide range of clinical trials under contract. The company supports medical institutions suitable for respective trials to improve the quality and speed of clinical trials. It generates additional revenue through software sales to medical institutions.
86GF Score

Get the complete analysis for FRA:TON

Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.40
Price
€25.57
GF Value